Merrimack Pharmaceuticals, Inc. - stock earnings
MACK Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -240000 USD | ? USD |
| 2023Q3 | -279000 USD | ? USD |
| 2023Q2 | -391000 USD | ? USD |
| 2023Q1 | -95000 USD | ? USD |
| 2022Q4 | -492000 USD | -445000 USD |
| 2022Q3 | -318000 USD | ? USD |
| 2022Q2 | -462000 USD | ? USD |
| 2022Q1 | -132000 USD | ? USD |
| 2021Q4 | -475000 USD | -144000 USD |
| 2021Q3 | -525000 USD | ? USD |
| 2021Q2 | -759000 USD | ? USD |
| 2021Q1 | -696000 USD | ? USD |
| 2020Q4 | -1.1 million USD | ? USD |
| 2020Q3 | -1.0 million USD | ? USD |
| 2020Q2 | -1.2 million USD | ? USD |
| 2020Q1 | 249000 USD | ? USD |
| 2019Q4 | 3.3 million USD | ? USD |
| 2019Q3 | -705000 USD | ? USD |
| 2019Q2 | -9.4 million USD | ? USD |
| 2019Q1 | -10.5 million USD | ? USD |
| 2018Q4 | -8.9 million USD | ? USD |
| 2018Q3 | 4.0 million USD | ? USD |
| 2018Q2 | -17.8 million USD | ? USD |
| 2018Q1 | -17.8 million USD | ? USD |
| 2017Q4 | -13.0 million USD | ? USD |
| 2017Q3 | 3.1 million USD | ? USD |
| 2017Q2 | 511.6 million USD | ? USD |
| 2017Q1 | -29.7 million USD | 61.2 million USD |
| 2016Q4 | -32.4 million USD | 61.2 million USD |
| 2016Q3 | -30.1 million USD | 28.1 million USD |
| 2016Q2 | -50.8 million USD | 33.7 million USD |
| 2016Q1 | -38.5 million USD | 21.3 million USD |
| 2015Q4 | -47.8 million USD | 21.4 million USD |
| 2015Q3 | -42.6 million USD | 16.4 million USD |
| 2015Q2 | -22.8 million USD | 36.6 million USD |
| 2015Q1 | -34.8 million USD | 14.8 million USD |
| 2014Q4 | -9.7 million USD | 33.9 million USD |
| 2014Q3 | -27.9 million USD | 28.0 million USD |
| 2014Q2 | -18.1 million USD | 27.8 million USD |
| 2014Q1 | -27.6 million USD | 13.0 million USD |
| 2013Q4 | -33.1 million USD | 7.8 million USD |
| 2013Q3 | -39.6 million USD | 6.9 million USD |
| 2013Q2 | -30.1 million USD | 18.5 million USD |
| 2013Q1 | -28.2 million USD | 14.7 million USD |
| 2012Q4 | -24.8 million USD | 14.2 million USD |
| 2012Q3 | -23.2 million USD | 11.3 million USD |
| 2012Q2 | -20.0 million USD | 12.1 million USD |
| 2012Q1 | -23.3 million USD | 11.3 million USD |
| 2011Q4 | -18.1 million USD | 12.6 million USD |
| 2011Q3 | -18.6 million USD | 8.6 million USD |
| 2011Q2 | -29.1 million USD | 6.6 million USD |
| 2011Q1 | -13.5 million USD | 6.5 million USD |
| 2010Q4 | -10.1 million USD | 6.3 million USD |
| 2010Q3 | -13.7 million USD | 5.7 million USD |
| 2010Q2 | -13.2 million USD | 4.3 million USD |
| 2010Q1 | -13.1 million USD | 4.0 million USD |
| 2009Q4 | ? USD | 2.1 million USD |
MACK Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -1.2 million USD | ? USD |
| 2022 | -1.5 million USD | -445000 USD |
| 2021 | -2.5 million USD | ? USD |
| 2020 | -3.0 million USD | ? USD |
| 2019 | -21.3 million USD | ? USD |
| 2018 | -40.5 million USD | ? USD |
| 2017 | 472.0 million USD | ? USD |
| 2016 | -151.7 million USD | 144.3 million USD |
| 2015 | -148.0 million USD | 89.3 million USD |
| 2014 | -83.3 million USD | 102.8 million USD |
| 2013 | -130.9 million USD | 47.8 million USD |
| 2012 | -91.3 million USD | 48.9 million USD |
| 2011 | -79.2 million USD | 34.2 million USD |
| 2010 | -50.1 million USD | 20.3 million USD |
| 2009 | -49.1 million USD | 2.1 million USD |
MACK
Price: $15
52 week price:
Earnings Per Share: -0.08 USD
P/E Ratio: -138
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 32078
Ebitda: -5.0 millionMarket Capitalization: 213.8 million